Literature DB >> 2110548

Human IFN-gamma up-regulates IL-2 receptors in mitogen-activated T lymphocytes.

M A Rodriguez1, J B De Sanctis, A M Blasini, M Leon-Ponte, I Abadi.   

Abstract

This study examined the role of human recombinant interferon-gamma (rIFN-gamma) in the expression of interleukin-2 receptors (IL-2R) by human T lymphocytes. rIFN-gamma enhanced total numbers of IL-2R in mitogen-activated but not resting T cells. Scatchard plot analysis indicated that rIFN-gamma increased both high- and low-affinity receptors, with a predominant effect on the latter. Phytohaemagglutinin (PHA)-activated T cells treated with IFN-gamma showed higher IL-2 binding and greater IL-2 internalization and degradation than cells treated with PHA alone. There was a corresponding increase of mitogen-driven proliferative responses, indicating an increase of functional receptors in IFN-treated cultures. IFN-gamma may influence T-cell activation and proliferation by enhancing expression of IL-2R and promoting IL-2 uptake by mitogen-activated lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110548      PMCID: PMC1385628     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Recombinant interferon-gamma induces interleukin 2 receptors on human peripheral blood monocytes.

Authors:  W Holter; R Grunow; H Stockinger; W Knapp
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

2.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

3.  Pure interferon gamma enhances class II HLA antigens on human monocyte cell lines.

Authors:  J L Virelizier; N Perez; F Arenzana-Seisdedos; R Devos
Journal:  Eur J Immunol       Date:  1984-01       Impact factor: 5.532

4.  Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons.

Authors:  M B Sztein; P S Steeg; H M Johnson; J J Oppenheim
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

5.  Retrovirus-induced expression of interleukin 2 receptors on cells of human B-cell lineage.

Authors:  K Sugamura; M Fujii; N Kobayashi; M Sakitani; M Hatanaka; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

6.  Purification and partial sequence analysis of human T-cell growth factor.

Authors:  R J Robb; R M Kutny; V Chowdhry
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

7.  Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes.

Authors:  P M Guyre; P M Morganelli; R Miller
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

8.  Retention of biological activity following radioiodination of human interleukin 2: comparison with biosynthetically labeled growth factor in receptor binding assays.

Authors:  R J Robb; P C Mayer; R Garlick
Journal:  J Immunol Methods       Date:  1985-07-16       Impact factor: 2.303

9.  A larger number of L chains (Tac) enhance the association rate of interleukin 2 to the high affinity site of the interleukin 2 receptor.

Authors:  Y Saito; H Sabe; N Suzuki; S Kondo; T Ogura; A Shimizu; T Honjo
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

10.  Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells.

Authors:  F Herrmann; S A Cannistra; H Levine; J D Griffin
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

View more
  2 in total

1.  Suppression of blastogenesis and proliferation of activated CD4(+) T cells: intravenous immunoglobulin (IVIg) versus novel anti-human leucocyte antigen (HLA)-E monoclonal antibodies mimicking HLA-I reactivity of IVIg.

Authors:  M H Ravindranath; P I Terasaki; T Pham; V Jucaud; S Kawakita
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

Review 2.  Therapeutic Potential of HLA-I Polyreactive mAbs Mimicking the HLA-I Polyreactivity and Immunoregulatory Functions of IVIg.

Authors:  Mepur H Ravindranath; Fatiha El Hilali; Edward J Filippone
Journal:  Vaccines (Basel)       Date:  2021-06-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.